chr9-136430325-C-T

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong

The NM_019892.6(INPP5E):​c.1754G>A​(p.Arg585His) variant causes a missense change. The variant allele was found at a frequency of 0.0000522 in 1,552,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R585C) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000053 ( 0 hom. )

Consequence

INPP5E
NM_019892.6 missense

Scores

12
6
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 6.99
Variant links:
Genes affected
INPP5E (HGNC:21474): (inositol polyphosphate-5-phosphatase E) The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.968
PP5
Variant 9-136430325-C-T is Pathogenic according to our data. Variant chr9-136430325-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 217657.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-136430325-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
INPP5ENM_019892.6 linkuse as main transcriptc.1754G>A p.Arg585His missense_variant 9/10 ENST00000371712.4 NP_063945.2 Q9NRR6-1
INPP5ENM_001318502.2 linkuse as main transcriptc.1751G>A p.Arg584His missense_variant 9/10 NP_001305431.1 Q9NRR6
INPP5EXM_017014926.2 linkuse as main transcriptc.1754G>A p.Arg585His missense_variant 9/10 XP_016870415.1
INPP5EXM_047423603.1 linkuse as main transcriptc.1751G>A p.Arg584His missense_variant 9/10 XP_047279559.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
INPP5EENST00000371712.4 linkuse as main transcriptc.1754G>A p.Arg585His missense_variant 9/101 NM_019892.6 ENSP00000360777.3 Q9NRR6-1
INPP5EENST00000676019.1 linkuse as main transcriptc.1652G>A p.Arg551His missense_variant 9/10 ENSP00000501984.1 Q9NRR6-2
INPP5EENST00000674693.1 linkuse as main transcriptn.*10G>A downstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152220
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000572
AC:
9
AN:
157454
Hom.:
0
AF XY:
0.0000483
AC XY:
4
AN XY:
82838
show subpopulations
Gnomad AFR exome
AF:
0.000113
Gnomad AMR exome
AF:
0.000121
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000867
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000491
Gnomad OTH exome
AF:
0.000225
GnomAD4 exome
AF:
0.0000529
AC:
74
AN:
1399930
Hom.:
0
Cov.:
35
AF XY:
0.0000434
AC XY:
30
AN XY:
690530
show subpopulations
Gnomad4 AFR exome
AF:
0.0000316
Gnomad4 AMR exome
AF:
0.0000840
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000621
Gnomad4 OTH exome
AF:
0.0000517
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152220
Hom.:
0
Cov.:
33
AF XY:
0.0000403
AC XY:
3
AN XY:
74362
show subpopulations
Gnomad4 AFR
AF:
0.000121
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000494
Hom.:
0
Bravo
AF:
0.0000189
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.0000103
AC:
1

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial aplasia of the vermis Pathogenic:2
Pathogenic, criteria provided, single submitterresearchUW Hindbrain Malformation Research Program, University of WashingtonFeb 23, 2015- -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 19, 2024This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 585 of the INPP5E protein (p.Arg585His). This variant is present in population databases (rs752300607, gnomAD 0.02%). This missense change has been observed in individual(s) with Joubert syndrome and/or rod cone degeneration (PMID: 26092869, 34188062). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 217657). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt INPP5E protein function with a positive predictive value of 80%. This variant disrupts the p.Arg585 amino acid residue in INPP5E. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23386033, 28559085). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
INPP5E-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesDec 01, 2023The INPP5E c.1754G>A variant is predicted to result in the amino acid substitution p.Arg585His. This variant along with a second variant in this gene was reported in an individual with Joubert syndrome (Table S5, Bachmann-Gagescu et al 2015. PubMed ID: 26092869) and found in two families with mild retinal degenerations (Table 1 and Figure 1, Sangermano et al 2021. PubMed ID: 34188062). This variant was reported as pathogenic in a carrier screening study (Table S1, Capalbo A et al 2019. PubMed ID: 31589614). This variant is reported in 0.023% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-139324777-C-T). In ClinVar, this variant is interpreted as uncertain/likly pathogenic/pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/217657/?new_evidence=false). A different variant affecting the same amino acid p.Arg585Cys has been reported in the compound heterozygous state in several affected individuals from two unrelated families with Joubert syndrome (Table1, Travaglini. 2013. PubMed ID: 23386033;Toma. 2018. PubMed ID: 29987673). Take together, this variant is interpreted as likely pathogenic. -
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxDec 19, 2024In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34426522, 31589614, 23386033, 33057194, 31964843, 29987673, 35982159, 26092869, 34188062, 28559085, 38113761, 38219857) -
Rod-cone dystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitterresearchOcular Genomics Institute, Massachusetts Eye and EarApr 08, 2021The INPP5E c.1754G>A variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PP3, PM1, PM3. Based on this evidence we have classified this variant as Likely Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.66
BayesDel_addAF
Pathogenic
0.32
D
BayesDel_noAF
Pathogenic
0.45
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.87
D
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.80
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.88
D
MetaRNN
Pathogenic
0.97
D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Uncertain
2.6
M
PrimateAI
Uncertain
0.73
T
PROVEAN
Uncertain
-3.8
D
REVEL
Pathogenic
0.91
Sift
Uncertain
0.0060
D
Sift4G
Uncertain
0.0040
D
Polyphen
1.0
D
Vest4
0.97
MutPred
0.82
Loss of MoRF binding (P = 0.0094);
MVP
0.99
MPC
1.2
ClinPred
0.93
D
GERP RS
5.5
Varity_R
0.83
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs752300607; hg19: chr9-139324777; API